Selected research
Market Structure
Global Dutasteride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Dutasteride market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Dutasteride include GSK, Amneal Pharma, Apotex, Bionpharma, Breckenridge Pharmaceutical, Marksans Pharma, Rising Pharmaceuticals, Zydus and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Dutasteride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Dutasteride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Dutasteride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dutasteride market size, projected growth trends, production technologies, key applications, and end-use industries.
Dutasteride Segment by Company
GSK
Amneal Pharma
Apotex
Bionpharma
Breckenridge Pharmaceutical
Marksans Pharma
Rising Pharmaceuticals
Zydus
Mylan
Teva
Dutasteride Segment by Type
Type I
Type II
Dutasteride Segment by Application
Hospital
Drug Store
Dutasteride Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dutasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dutasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dutasteride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dutasteride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dutasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dutasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Type I
- Type II
Applications
- Hospital
- Drug Store
Companies covered
- GSK
- Amneal Pharma
- Apotex
- Bionpharma
- Breckenridge Pharmaceutical
- Marksans Pharma
- Rising Pharmaceuticals
- Zydus
- Mylan
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Dutasteride Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Dutasteride Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Dutasteride Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Dutasteride Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Dutasteride Market Dynamics
- 2.1 Dutasteride Industry Trends
- 2.2 Dutasteride Industry Drivers
- 2.3 Dutasteride Industry Opportunities and Challenges
- 2.4 Dutasteride Industry Restraints
3 Dutasteride Market by Manufacturers
- 3.1 Global Dutasteride Revenue by Manufacturers (2021-2026)
- 3.2 Global Dutasteride Sales by Manufacturers (2021-2026)
- 3.3 Global Dutasteride Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Dutasteride Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Dutasteride Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Dutasteride Manufacturers, Product Type & Application
- 3.7 Global Dutasteride Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Dutasteride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Dutasteride Players Market Share by Revenue in 2025
- 3.8.3 2025 Dutasteride Tier 1, Tier 2, and Tier 3
4 Dutasteride Market by Type
- 4.1 Dutasteride Type Introduction
- 4.1.1 Type I
- 4.1.2 Type II
- 4.2 Global Dutasteride Sales by Type
- 4.2.1 Global Dutasteride Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Dutasteride Sales by Type (2021-2032)
- 4.2.3 Global Dutasteride Sales Market Share by Type (2021-2032)
- 4.3 Global Dutasteride Revenue by Type
- 4.3.1 Global Dutasteride Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Dutasteride Revenue by Type (2021-2032)
- 4.3.3 Global Dutasteride Revenue Market Share by Type (2021-2032)
5 Dutasteride Market by Application
- 5.1 Dutasteride Application Introduction
- 5.1.1 Hospital
- 5.1.2 Drug Store
- 5.2 Global Dutasteride Sales by Application
- 5.2.1 Global Dutasteride Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Dutasteride Sales by Application (2021-2032)
- 5.2.3 Global Dutasteride Sales Market Share by Application (2021-2032)
- 5.3 Global Dutasteride Revenue by Application
- 5.3.1 Global Dutasteride Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Dutasteride Revenue by Application (2021-2032)
- 5.3.3 Global Dutasteride Revenue Market Share by Application (2021-2032)
6 Global Dutasteride Sales by Region
- 6.1 Global Dutasteride Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Dutasteride Sales by Region (2021-2032)
- 6.2.1 Global Dutasteride Sales by Region (2021-2026)
- 6.2.2 Global Dutasteride Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Dutasteride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Dutasteride Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Dutasteride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Dutasteride Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Dutasteride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Dutasteride Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Dutasteride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Dutasteride Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Dutasteride Revenue by Region
- 7.1 Global Dutasteride Revenue by Region
- 7.1.1 Global Dutasteride Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Dutasteride Revenue by Region (2021-2026)
- 7.1.3 Global Dutasteride Revenue by Region (2027-2032)
- 7.1.4 Global Dutasteride Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Dutasteride Revenue (2021-2032)
- 7.2.2 North America Dutasteride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Dutasteride Revenue (2021-2032)
- 7.3.2 Europe Dutasteride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Dutasteride Revenue (2021-2032)
- 7.4.2 Asia-Pacific Dutasteride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Dutasteride Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Dutasteride Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 GSK
- 8.1.1 GSK Company Information
- 8.1.2 GSK Business Overview
- 8.1.3 GSK Dutasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 GSK Dutasteride Product Portfolio
- 8.1.5 GSK Recent Developments
- 8.2 Amneal Pharma
- 8.2.1 Amneal Pharma Company Information
- 8.2.2 Amneal Pharma Business Overview
- 8.2.3 Amneal Pharma Dutasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Amneal Pharma Dutasteride Product Portfolio
- 8.2.5 Amneal Pharma Recent Developments
- 8.3 Apotex
- 8.3.1 Apotex Company Information
- 8.3.2 Apotex Business Overview
- 8.3.3 Apotex Dutasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Apotex Dutasteride Product Portfolio
- 8.3.5 Apotex Recent Developments
- 8.4 Bionpharma
- 8.4.1 Bionpharma Company Information
- 8.4.2 Bionpharma Business Overview
- 8.4.3 Bionpharma Dutasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bionpharma Dutasteride Product Portfolio
- 8.4.5 Bionpharma Recent Developments
- 8.5 Breckenridge Pharmaceutical
- 8.5.1 Breckenridge Pharmaceutical Company Information
- 8.5.2 Breckenridge Pharmaceutical Business Overview
- 8.5.3 Breckenridge Pharmaceutical Dutasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Breckenridge Pharmaceutical Dutasteride Product Portfolio
- 8.5.5 Breckenridge Pharmaceutical Recent Developments
- 8.6 Marksans Pharma
- 8.6.1 Marksans Pharma Company Information
- 8.6.2 Marksans Pharma Business Overview
- 8.6.3 Marksans Pharma Dutasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Marksans Pharma Dutasteride Product Portfolio
- 8.6.5 Marksans Pharma Recent Developments
- 8.7 Rising Pharmaceuticals
- 8.7.1 Rising Pharmaceuticals Company Information
- 8.7.2 Rising Pharmaceuticals Business Overview
- 8.7.3 Rising Pharmaceuticals Dutasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Rising Pharmaceuticals Dutasteride Product Portfolio
- 8.7.5 Rising Pharmaceuticals Recent Developments
- 8.8 Zydus
- 8.8.1 Zydus Company Information
- 8.8.2 Zydus Business Overview
- 8.8.3 Zydus Dutasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Zydus Dutasteride Product Portfolio
- 8.8.5 Zydus Recent Developments
- 8.9 Mylan
- 8.9.1 Mylan Company Information
- 8.9.2 Mylan Business Overview
- 8.9.3 Mylan Dutasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Mylan Dutasteride Product Portfolio
- 8.9.5 Mylan Recent Developments
- 8.10 Teva
- 8.10.1 Teva Company Information
- 8.10.2 Teva Business Overview
- 8.10.3 Teva Dutasteride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Teva Dutasteride Product Portfolio
- 8.10.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Dutasteride Value Chain Analysis
- 9.1.1 Dutasteride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Dutasteride Production Mode & Process
- 9.2 Dutasteride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Dutasteride Distributors
- 9.2.3 Dutasteride Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst